Your Article Summary
See Latest ArticlesThe benefits and risks of testosterone replacement therapy: a review
Therapeutics and Clinical Risk Management, 06/12/09
Bassil N et al. - The indication of testosterone-replacement therapy (TRT) treatment requires the presence of low testosterone level, and symptoms and signs of hypogonadism. Although controversy remains regarding indications for testosterone supplementation in aging men due to lack of large-scale, long-term studies assessing the benefits and risks of testosterone-replacement therapy in men, reports indicate that TRT may produce a wide range of benefits for men with hypogonadism that include improvement in libido and sexual function, bone density, muscle mass, body composition, mood, erythropoiesis, cognition, quality of life and cardiovascular disease. Perhaps the most controversial area is the issue of risk, especially possible stimulation of prostate cancer by testosterone, even though no evidence to support this risk exists. Other possible risks include worsening symptoms of benign prostatic hypertrophy, liver toxicity, hyperviscosity, erythrocytosis, worsening untreated sleep apnea or severe heart failure. The physician should discuss with the patient the potential benefits and risks of TRT. The purpose of this review is to discuss what is known and not known regarding the benefits and risks of TRT.
Related Articles
Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09
Relevance Score: 81%
Testosterone therapy and prostate carcinoma
Current Urology Reports, 11/17/09
Relevance Score: 80%
Is androgen therapy indicated for aging men?
Sexuality, Reproduction & Menopause, 10/05/09
Relevance Score: 80%
NIH-Supported Trial to Study Testosterone Therapy in Older Men
MedLinePlus, 11/04/09
Relevance Score: 68%
Testosterone supplementation: For whom and when?
Sexuality, Reproduction & Menopause, 10/08/09
Relevance Score: 68%
Today in Endocrine...keeping you current
Receive free subspecialty "5-minute updates" via email
Oestrogenic mycotoxin exposures and precocious pubertal development
International Journal of Andrology, 12/03/09
Kisspeptin/GPR54 system as potential target for endocrine disruption of reproductive development and function
International Journal of Andrology, 11/13/09
Timetable of effects of testosterone administration to hypogonadal men on variables of sex and mood
The Aging Male, 11/13/09